Mycobacterium avium genotype is associated with the therapeutic response to lung infection

Clinical Microbiology and Infection

Volumn 20, Issue 3, 2014, Pages 256-262

  Kikuchi, T ^a,b   Kobashi, Y ^c   Hirano, T ^a   Tode, N ^a   Santoso, A ^a   Tamada, T ^b   Fujimura, S ^d   Mitsuhashi, Y ^a   Honda, Y ^a   Nukiwa, T ^a   Kaku, M ^a   Watanabe, A ^d   Ichinose, M ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Logistic regression analysis; Mycobacterium avium; Principal component analysis; Therapeutic response; Variable number tandem repeats

Indexed keywords

CLARITHROMYCIN; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASTHMA; BACTERIUM ISOLATE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG CANCER; LUNG INFECTION; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT; AGED; ANIMAL; ANTIBIOTIC RESISTANCE; CLUSTER ANALYSIS; DRUG EFFECTS; GENE LOCUS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; ODDS RATIO; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM AVIUM;

AGED; ANIMALS; ANTITUBERCULAR AGENTS; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENETIC LOCI; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINISATELLITE REPEATS; MYCOBACTERIUM AVIUM; ODDS RATIO; PHYLOGENY; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84893811992     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12285     Document Type: Article

References (30)

1. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008; 133: 243-251.
2. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ats/idsa statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
3. Henry MT, Inamdar L, O'Riordain D, Schweiger M, Watson JP. Nontuberculous mycobacteria in non-hiv patients: epidemiology, treatment and response. Eur Respir J 2004; 23: 741-746.
4. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in ontario, 1997 2003. Thorax 2007; 62: 661-666.
5. Thomson RM, Yew WW. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009; 14: 12-26.
6. van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012; 15: 149-161.
7. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of mycobacterium vaccae immunotherapy. Thorax 2008; 63: 627-634.
8. Behr MA, Falkinham JO III. Molecular epidemiology of nontuberculous mycobacteria. Future Microbiol 2009; 4: 1009-1020.
9. Neonakis IK, Gitti Z, Krambovitis E, Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods 2008; 75: 1-11.
10. Oelemann MC, Diel R, Vatin V et al. Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol 2007; 45: 691-697.
11. Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the mycobacterium tuberculosis genome. Mol Microbiol 2000; 36: 762-771.
12. Inagaki T, Nishimori K, Yagi T et al. Comparison of a variable-number tandem-repeat (vntr) method for typing mycobacterium avium with mycobacterial interspersed repetitive-unit-vntr and is1245 restriction fragment length polymorphism typing. J Clin Microbiol 2009; 47: 2156-2164.
13. Kikuchi T, Watanabe A, Gomi K et al. Association between mycobacterial genotypes and disease progression in mycobacterium avium pulmonary infection. Thorax 2009; 64: 901-907.
14. Kobashi Y, Abe M, Mouri K, Obase Y, Kato S, Oka M. Relationship between clinical efficacy for pulmonary mac and drug-sensitivity test for isolated mac in a recent 6-year period. J Infect Chemother 2012; 18: 436-443.
15. Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K, Marras TK. Aging, copd, and other risk factors do not explain the increased prevalence of pulmonary mycobacterium avium complex in ontario. Chest 2012; 141: 190-197.
16. Ignatov D, Kondratieva E, Azhikina T, Apt A. Mycobacterium avium-triggered diseases: pathogenomics. Cell Microbiol 2012; 14: 808-818.
17. Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria. Semin Respir Infect 1996; 11: 244-251.
18. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
19. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11: 321-333.
20. Olivier KN, Weber DJ, Wallace RJ Jr. et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167: 828-834.
21. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by mycobacterium avium complex. Am Rev Respir Dis 1991; 144: 914-916.
22. Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW. Nramp1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 2005; 128: 94-101.
23. Sapkota BR, Hijikata M, Matsushita I et al. Association of slc11a1 (nramp1) polymorphisms with pulmonary mycobacterium avium complex infection. Hum Immunol 2012; 73: 529-536.
24. Shojima J, Tanaka G, Keicho N et al. Identification of mica as a susceptibility gene for pulmonary mycobacterium avium complex infection. J Infect Dis 2009; 199: 1707-1715.
25. Takahashi M, Ishizaka A, Nakamura H et al. Specific hla in pulmonary mac infection in a japanese population. Am J Respir Crit Care Med 2000; 162: 316-318.
26. Tanaka G, Shojima J, Matsushita I et al. Pulmonary mycobacterium avium complex infection: association with nramp1 polymorphisms. Eur Respir J 2007; 30: 90-96.
27. Um SW, Ki CS, Kwon OJ, Koh WJ. Hla antigens and nontuberculous mycobacterial lung disease in korean patients. Lung 2009; 187: 136-140.
28. Yim JJ, Kim HJ, Kwon OJ, Koh WJ. Association between microsatellite polymorphisms in intron ii of the human toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a korean population. Hum Immunol 2008; 69: 572-576.
29. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacterium avium-intracellulare pulmonary infection in hiv-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999; 115: 1033-1040.
30. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 hiv-negative patients with mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 185: 575-583.